News

The President of the ABPI and the Director of the PMCPA have recently highlighted the need to ensure that advisory board meetings mee​t the requirements of the Code.​ ​

Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure were agreed at the Half Yearly General Meeting of the ABPI on 11 November.  Further changes were agreed at a special meeting of the ABPI on 1 December.​

We are seeking to appoint a new independent member, from an independent body involved with providing information on medicines, to the Code of Practice Appeal Board in 2016.

Proposals for amendment of the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure were agreed at the Half Yearly General Meeting of the ABPI on 11 November. 

Further consultation on proposed changes to the ABPI Code of Practice for the Pharmaceutical Industry.

Astellas Pharmaceuticals Limited will be named in advertisements(1) following breaches of the ABPI Code of Practice for the Pharmaceutical Industry.

Consultation launched on proposed changes to the ABPI Code of Practice for the Pharmaceutical Industry and the Constitution and Procedure for the Prescription Medicines Code of Practice Authority.

We are seeking to appoint three new independent members to the Code of Practice Appeal Board in 2015.

Sanofi and Otsuka have each breached Clause 2 of the Code and are subject to advertisements in the medical, pharmaceutical and nursing press. In addition Sanofi was publicly reprimanded.

Chiesi has been publicly reprimanded for providing inaccurate information to the PMCPA during the course of a complaint about a leave piece and again during the course of a subsequent audit ​and is the subject of advertisements in the medical, pharmaceutical and nursing press.

Galderma UK Ltd and Merck Serono have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press.

Proposals to amend the Code agreed at ABPI General Meeting on 20 November.
​​​​​Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure were agreed at the Half Yearly General Meeting of the ABPI on 20 November 2014.